Citigroup
TNYA icon

Citigroup’s Tenaya Therapeutics TNYA Stock Holding History

Citigroup’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.3K Buy
92,417
+46,375
+101% +$35.2K ﹤0.01% 4872
2026
Q1 		$31.9K Buy
46,042
+22,567
+96% +$16.7K ﹤0.01% 4682
2025
Q4 		$16.7K Buy
23,475
+22,634
+2,691% +$30.8K ﹤0.01% 4917
2025
Q3 		$1.36K Sell
841
-35,838
-98% -$36.1K ﹤0.01% 5580
2025
Q2 		$22.4K Sell
36,679
-2,095
-5% -$1.07K ﹤0.01% 5047
2025
Q1 		$22.1K Sell
38,774
-4,733
-11% -$4.67K ﹤0.01% 5071
2024
Q4 		$62.2K Buy
43,507
+3,400
+8% +$7.62K ﹤0.01% 5024
2024
Q3 		$77.4K Buy
40,107
+27,793
+226% +$78.5K ﹤0.01% 4877
2024
Q2 		$38.2K Sell
12,314
-1,795
-13% -$7.41K ﹤0.01% 4732
2024
Q1 		$73.8K Buy
14,109
+7,307
+107% +$35K ﹤0.01% 4433
2023
Q4 		$22K Buy
6,802
+6,320
+1,311% +$13.6K ﹤0.01% 4956
2023
Q3 		$1.23K Sell
482
-13,608
-97% -$57K ﹤0.01% 5061
2023
Q2 		$82.7K Buy
14,090
+13,651
+3,110% +$79.3K ﹤0.01% 4336
2023
Q1 		$1.25K Sell
439
-250
-36% -$703 ﹤0.01% 5141
2022
Q4 		$1.39K Sell
689
-160,837
-100% -$393K ﹤0.01% 5346
2022
Q3 		$468K Buy
161,526
+158,807
+5,841% +$741K ﹤0.01% 3280
2022
Q2 		$15K Buy
2,719
+716
+36% +$5.79K ﹤0.01% 5160
2022
Q1 		$24K Sell
2,003
-2,818
-58% -$34.1K ﹤0.01% 5061
2021
Q4 		$91K Buy
4,821
+3,232
+203% +$70.4K ﹤0.01% 4782
2021
Q3 		$33K Buy
+1,589
New +$34.1K ﹤0.01% 4984

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup's TNYA Position: Q2 2026 in Review

Citigroup increased its Tenaya Therapeutics (TNYA) stake by 101% in Q2 2026, buying an estimated $35.2K and bringing the position to 92,417 shares worth $68.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4872.

Citigroup first reported a position in TNYA in Q3 2021 and has held it in 20 quarters since. The position peaked at $468K in Q3 2022. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Citigroup held 92,417 shares of Tenaya Therapeutics worth $68.3K as of Q2 2026.
  • Citigroup bought 46,375 Tenaya Therapeutics shares in Q2 2026, an estimated $35.2K.
  • Tenaya Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4872 holding.
  • Citigroup first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Citigroup's Tenaya Therapeutics position peaked at $468K in Q3 2022.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.